Trial Profile
The effect of St John's Wort on pharmacokinetics and pharmacodynamics of Repaglinide.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2012
Price :
$35
*
At a glance
- Drugs Repaglinide (Primary) ; Hypericum
- Indications Diabetes mellitus; Major depressive disorder
- Focus Pharmacodynamics; Pharmacokinetics
- 01 Sep 2011 Results published in the Clinical Pharmacokinetics.
- 30 Jun 2009 New trial record